Feds call for pause of Johnson and Johnson COVID-19 vaccine

1
563
A researcher at Protein Sciences reaches for a vial in a lab, Thursday, March 12, 2020, in Meriden, Conn. The biotech company is currently researching a vaccine for COVID-19. For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The vast majority of people recover from the new virus. (AP Photo/Jessica Hill)

U.S. health leaders are hitting the brakes on the distribution of the one-dose Johnson & Johnson COVID-19 vaccine after a number of patients developed a rare blood disorder.

All six patients are women between the ages of 18 and 48, and all have developed blood clots as a result of the disorder. One of the women has died, and another is hospitalized in critical condition.

The Centers for Disease Control and Prevention says almost seven million Americans have received the J&J version of the vaccine. The Food and Drug Administration says the announcement counts as a strong recommendation that state health officials stop using that version of the vaccine, while its usage at all federally-run clinics will be paused while scientists take another look at whether or not it is safe for the general public to use.

Read the full announcement here. The CDC will hold a press conference at 10am, which you will be able to watch here.

Both the Pfizer and Moderna two-dose vaccines are still considered safe to use.

1 COMMENT

  1. So 7 deaths out of 6 million traditional dead virus shots is cause for worry, but the mRNA shots are still just fine despite their deaths and side effects? Admittedly, news of those have been heavily suppressed by our benevolent overlords.

    The tinfoil hat is telling me that the government wants people to get the mutantRNA shots for some reason. I wonder why that could ever be?

LEAVE A REPLY

Please enter your comment!
Please enter your name here